Stemper B, Lowen S, Fritsch A, Hoffmann A, et al. The bradykinin-1 receptor antagonist fulmetibant in patients with diabetic neuropathic pain: the randomized, crossover, placebo-controlled, double-blind, phase 2a BRADiNP study. Pain 2025 May 6. doi: 10.1097/j.pain.0000000000003642.
PMID: 40334047